| Serial Number | 79284229 |
| Word Mark | EVERZOM |
| Filing Date | Wednesday, March 4, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 19, 2021 |
| Registration Number | 6248149 |
| Registration Date | Tuesday, January 19, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 3, 2020 |
| Goods and Services | Medical services, namely, regenerative medicine services using extracellular vesicles; stem cell therapy services, namely, therapy services based on stem cells; biotherapy services, namely, health care therapy services for treating cancer, cardiovascular diseases, acute kidney injury, brain injury, liver injury, osteoarthrisis, bone regeneration, lung injury, cutaneous wound healing, fistula, stenosis, radio induced fibrosis, autoimmune diseases, lysosomal storage disorders, degenerative diseases, using extracellular vesicles; biotherapy services, namely, medical services relating to the collection, treatment and processing of human cells |
| Goods and Services | Medical research and pharmacological research services; analysis of human tissues for medical research purposes; pharmaceutical drug development services, namely, development of pharmaceutical preparations and medicines from extracellular vesicles; conducting clinical trials for others; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; medical research and laboratory services in the field of human tissue, namely, tissue engineering; medical research services, namely, clinical research in the field of biotherapy; conducting clinical trials for others, namely, carrying out clinical trials for pharmaceutical products; testing on pharmaceutical products; quality control for others, namely, quality evaluation of pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; medical research services, namely, biological, clinical and medical research services in the field of biotherapy; scientific research for medical purposes in the field of biotherapy; scientific research in the field of extracellular vesicles, namely, scientific research in the field of analysis, isolation and production of extracellular vesicles; laboratory research services concerning pharmaceutical products; stem cell research; scientific research and development in the field of microorganisms and cells; scientific research and development in the field of extracellular vesicles; scientific research services with respect to the isolation and cultivation of human cells and tissues |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 1, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 1, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EVERZOM |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | EVERZOM |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | EVERZOM |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Event Date | Event Description |
| Sunday, December 24, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, May 16, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, April 23, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, April 23, 2021 | FINAL DISPOSITION PROCESSED |
| Monday, April 19, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, January 19, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 3, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 14, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, September 28, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, September 28, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 28, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, September 28, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Monday, September 28, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, September 9, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 8, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 8, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, July 18, 2020 | REFUSAL PROCESSED BY IB |
| Wednesday, July 1, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, June 30, 2020 | REFUSAL PROCESSED BY MPU |
| Sunday, May 31, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, May 30, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, May 21, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, May 5, 2020 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 1, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 30, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |